Mutations linked to CPVT are typically associated with gain of function of RyR2 SR Ca2+ release complex that promotes arrhythmogenic spontaneous SR Ca2+ release (Fig. 1). The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.